Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R.

J Med Chem. 2014 Apr 10;57(7):3075-93. doi: 10.1021/jm500039e. Epub 2014 Mar 31.

PMID:
24625106
2.

Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R.

J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.

3.

SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.

Zhu X, Van Horn KS, Barber MM, Yang S, Wang MZ, Manetsch R, Werbovetz KA.

Bioorg Med Chem. 2015 Aug 15;23(16):5182-9. doi: 10.1016/j.bmc.2015.02.020. Epub 2015 Feb 18.

4.

Relationship between structure and antibacterial activity of lipophilic N-acyldiamines.

de Almeida CG, Garbois GD, Amaral LM, Diniz CC, Le Hyaric M.

Biomed Pharmacother. 2010 Apr;64(4):287-90. doi: 10.1016/j.biopha.2009.09.013. Epub 2009 Nov 5.

PMID:
19942397
5.

Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.

Li X, Hilgers M, Cunningham M, Chen Z, Trzoss M, Zhang J, Kohnen L, Lam T, Creighton C, G C K, Nelson K, Kwan B, Stidham M, Brown-Driver V, Shaw KJ, Finn J.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5171-6. doi: 10.1016/j.bmcl.2011.07.059. Epub 2011 Jul 23.

PMID:
21831637
6.

Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents.

Kung PP, Casper MD, Cook KL, Wilson-Lingardo L, Risen LM, Vickers TA, Ranken R, Blyn LB, Wyatt JR, Cook PD, Ecker DJ.

J Med Chem. 1999 Nov 4;42(22):4705-13.

PMID:
10579832
7.

Antibacterial effect of some 2,6-disubstituted 4-anilinoquinazolines.

Gottasová R, Kubíková J, Cipák L.

Folia Microbiol (Praha). 1998;43(6):679-82.

PMID:
10189231
8.

Antibacterial effects of trisubstituted quinazoline derivatives.

Jantová S, Greif G, Spirková K, Stankovský S, Oravcová M.

Folia Microbiol (Praha). 2000;45(2):133-7.

PMID:
11271820
9.

Antibacterial Diamines Targeting Bacterial Membranes.

Wang B, Pachaiyappan B, Gruber JD, Schmidt MG, Zhang YM, Woster PM.

J Med Chem. 2016 Apr 14;59(7):3140-51. doi: 10.1021/acs.jmedchem.5b01912. Epub 2016 Mar 28.

PMID:
26964758
10.

Bis-phosphonium salts of pyridoxine: the relationship between structure and antibacterial activity.

Pugachev MV, Shtyrlin NV, Sapozhnikov SV, Sysoeva LP, Iksanova AG, Nikitina EV, Musin RZ, Lodochnikova OA, Berdnikov EA, Shtyrlin YG.

Bioorg Med Chem. 2013 Dec 1;21(23):7330-42. doi: 10.1016/j.bmc.2013.09.056. Epub 2013 Oct 1.

PMID:
24139168
11.

Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1997 Aug 22;46(33):765-6. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Sep 12;46(36):851.

12.

Identification of antimicrobial compounds active against intracellular Staphylococcus aureus.

Malouin F, Brouillette E, Martinez A, Boyll BJ, Toth JL, Gage JL, Allen NE.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):245-52.

13.

Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).

Song MX, Zheng CJ, Deng XQ, Sun LP, Wu Y, Hong L, Li YJ, Liu Y, Wei ZY, Jin MJ, Piao HR.

Eur J Med Chem. 2013 Feb;60:376-85. doi: 10.1016/j.ejmech.2012.12.007. Epub 2012 Dec 20.

PMID:
23314051
14.

Antimicrobial activity of some substituted triazoloquinazolines.

Jantová S, Ovádeková R, Letasiová S, Spirková K, Stankovský S.

Folia Microbiol (Praha). 2005;50(2):90-4.

PMID:
16110909
15.

DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.

Kaizerman JA, Gross MI, Ge Y, White S, Hu W, Duan JX, Baird EE, Johnson KW, Tanaka RD, Moser HE, Bürli RW.

J Med Chem. 2003 Aug 28;46(18):3914-29.

PMID:
12930152
16.

Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.

Ma X, Tan ST, Khoo CL, Sim HM, Chan LW, Chui WK.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5428-31. doi: 10.1016/j.bmcl.2011.06.125. Epub 2011 Jul 2.

PMID:
21788136
17.

The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model.

Nagl M, Hengster P, Semenitz E, Gottardi W.

J Antimicrob Chemother. 1999 Jun;43(6):805-9.

PMID:
10404319
18.

Systemic antibacterial activity of novel synthetic cyclic peptides.

Dartois V, Sanchez-Quesada J, Cabezas E, Chi E, Dubbelde C, Dunn C, Granja J, Gritzen C, Weinberger D, Ghadiri MR, Parr TR Jr.

Antimicrob Agents Chemother. 2005 Aug;49(8):3302-10.

19.

Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus.

Ghorab MM, Ismail ZH, Abdalla M, Radwan AA.

Arch Pharm Res. 2013 Jun;36(6):660-70. doi: 10.1007/s12272-013-0094-6.

PMID:
23529860
20.

Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.

Shao C, Zhou W, Zhang S, Wei W, Ruan L, Jin Y, Sun X, Huang Y.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6732-8. doi: 10.1016/j.bmcl.2011.09.045. Epub 2011 Sep 18.

PMID:
21978682

Supplemental Content

Support Center